In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
About Us

 

The Gold Standard in Life Sciences Strategic Insight
Strategy. Insights. Trends.

Biopharma. Medtech. Diagnostics.
In Vivo is the premiere resource for life sciences business strategy, covering the biopharma, medtech, and diagnostics industries in one authoritative package. With a unique understanding of the forces shaping global healthcare, In Vivo delivers the “so what” underpinning industry events, so you can make proactive, rather than reactive business decisions, broker deals with confidence, and identify opportunities your competitors might miss.

In Vivo brings you insider interviews with top industry executives, and thought provoking features that help you anticipate future industry trends and keep abreast on the latest in dealmaking, marketing, R&D, regulatory and finance strategies.

If you are a senior business strategist or a top industry executive needing to make sense of the rapidly changing healthcare environment – you need In Vivo.

 

GLOBAL CONTENT FROM TRUSTED EXPERTS

In Vivo’s global editorial team provides in-depth analysis and opinion of the events that matter to industry leaders. Sources and readers alike trust our coverage as independent, thorough and objective, thanks to our 35-year track record of excellence.

INSIGHT BEYOND THE HEADLINES

In Vivo does much more than just keep you up to date. By focusing on what’s behind the headlines and soundbites – we unravel the strategic implications of global industry news – so you can see what developments actually mean for your business.

UNPARALLELED ACCESS TO DATA AND DECISION-MAKERS

Our award-winning analysis is supplemented with best-in class proprietary data from across the Informa Pharma Intelligence product portfolio, and we tap into an impressive network of key decision makers and industry leaders.

POWERFUL DIGITAL PLATFORM

In Vivo content posts continually on a new user-friendly, digital platform that is responsive to any mobile device and includes a robust, boolean search and the ability to create custom, fully-responsive email alerts.

 

KEY AREAS OF COVERAGE

Growth: What are your competitors’ strategies for growing their business?
Innovation:Key new technologies and business models and their implications for your firm
Leadership: Exclusive interviews with top industry executives and analysts
Market Access: How to get your products to market with the right price and payer buy-in
Market Intelligence: We scour the data and reveal the numbers that will help you make the best decisions

RECURRING FEATURES

Execs on the Move | Deals Round-up | Deals in Depth | Deals of the Month | Biopharma & Medtech Quarterly Dealmaking Stats

PLUS

  • Hot Topics Pages, such as Personalized Medicine, The C-Suite Speaks, and others
  • Ask the Analyst - Exclusive service where our clients can ask our expert journalists and analysts questions about any of our news stories, data and analysis when they need additional information
  • Monthly PDF Archive
 

INVALUABLE INSIGHTS TO HELP:

  • Anticipate industry trends
  • Understand what’s happening beyond your areas of expertise
  • Identify risks & opportunities presented by disruptive innovation (new technologies, business models, deal structures, leadership styles)

Video, audio, and proprietary data sets br ing our articles and analyses to life.


Numerous search filters allow for precise content targeting, and articles and searches can be saved and shared with one-click


Set custom email alerts on any topic or search criteria so you never miss what you need to know most.

UsernamePublicRestriction

Register

Advertisement